News
GMP manufacturing completed, paediatric waiver granted, positive outcome from FDA and EMA interactions; advancing mitazalimab toward Phase 3 readinessBiomarker data from OPTIMIZE-1 presented at ASCO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results